Cite
HARVARD Citation
Thiele, E. et al. (2018). Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 391 (10125), pp. 1085-1096. [Online].